Enlivex Therapeutics Reschedules Annual Shareholders Meeting
Company Announcements

Enlivex Therapeutics Reschedules Annual Shareholders Meeting

Enlivex (ENLV) has released an update.

Enlivex Therapeutics Ltd. postponed its Annual General Meeting of Shareholders due to the absence of a quorum, rescheduling it for November 7, 2024. This delay highlights procedural challenges that can impact shareholder engagement and investor confidence. The meeting will take place at the company’s offices in Nes Ziona, Israel.

For further insights into ENLV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskEnlivex Initiates Promising Trial for Psoriatic Arthritis
TheFlyEnlivex completes dosing, follow-up for first patient in study of Allocetra
TipRanks Auto-Generated NewsdeskEnlivex Advances Allocetra Trial for Knee Osteoarthritis
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App